UN urges exit screening for Ebola at some airports (Update)

August 13, 2014 by John Heilprin

Ebola-affected countries should immediately begin exit screening all passengers leaving international airports, sea ports and major ground crossings, the U.N. health agency said on Monday.

The agency didn't spell out which countries should start screening passengers, but noted that the Ebola outbreak involves transmission in Guinea, Liberia and Sierra Leona and a "small number of people in Nigeria."

All countries, even those unaffected by the outbreak in West Africa, need to strengthen their ability to detect and immediately contain new cases without doing anything that unnecessarily interferes with international travel or trade, the agency said. But countries don't need to impose travel restrictions and active screening of passengers if they do not share borders with Ebola-affected countries, it said.

Authorities in Liberia, Sierra Leone and Guinea say they are already closely inspecting departing passengers for signs of fever or illness.

The risk of the Ebola virus being transmitted during air travel is low because unlike infections such as influenza or tuberculosis, it is not spread by breathing air and airborne particles from an infected person.

Nonetheless, the World Health Organization said anyone with an illness consistent with the virus should not be allowed to travel normally and all passengers should routinely wash their hands and avoid direct contact with body fluids of infected people.

"Transmission requires direct contact with blood, secretions, organs or other body fluids of infected living or dead persons or animals, all unlikely exposures for the average traveler," the agency said in a statement.

The only way to contain the disease, for which there is no licensed treatment, is by isolating the sick and closely watching for signs of infection in those they have come into contact with. A person usually has no symptoms for two to 21 days, but after the incubation period the symptoms include fever, weakness, muscle pain, headache and sore throat, according to WHO. Then comes vomiting, diarrhea, rash, and in some cases, bleeding.

The Geneva-based agency has been criticized by non-U.N. health organizations as being slow to call for an emergency response to the Ebola crisis.

Some countries have banned direct flights to states hit by the disease. British Airways, Kenya Airways and a number of regional carriers have also canceled flights to the capitals of Sierra Leone and Liberia despite the WHO's recommendation that no travel or trade bans be put in place.

Last month, a Liberian-American man infected with Ebola boarded a flight from Liberia to Nigeria and died days later; 11 people who came into contact with him have been infected.

A task force to monitor the impact of the Ebola virus on travel and transport has been launched by the U.N. health agency along with the International Civil Aviation Organization, the World Tourism Organization, the Airports Council International, the International Air Transport Association and the World Travel and Tourism Council.

Most of the infections in Liberia, Guinea and Sierra Leone have occurred when family members or friends act as caregivers for those who are ill or during burials that don't follow strict infection prevention and control measures, according to WHO officials.

Explore further: Sierra Leone defends its record on Ebola outbreak

Related Stories

WHO holds emergency Ebola meeting

August 6, 2014

The World Health Organization on Wednesday began a two-day emergency meeting on west Africa's Ebola epidemic, with the UN agency deciding whether to declare it an international crisis.

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.